Sangamo Therapeutics (SGMOQ) Receivables (2010 - 2025)
Sangamo Therapeutics (SGMOQ) posted Receivables of $400000.0 for Q4 2025, down 23.52% on a QoQ basis from $523000.0 in Q3 2025, and down 23.95% year-over-year from $526000.0 in Q4 2024.
Powered by 
Analysis
Sangamo Therapeutics (SGMOQ) Receivables (2010 - 2025) Analysis & Trends
Sangamo Therapeutics has reported Receivables for 16 years, with the latest figure at $400000.0 in Q4 2025.
- On a quarterly basis, Receivables fell 23.95% year-over-year to $400000.0 in Q4 2025; TTM through Dec 2025 was $400000.0, a 23.95% decrease from a year earlier, with the FY2025 full-year figure at $400000.0, down 23.95% from the prior year.
- Receivables was $400000.0 for Q4 2025 at Sangamo Therapeutics, down from $523000.0 in the prior quarter.
- The five-year high for Receivables was $20.5 million in Q3 2024, with the low at $366000.0 in Q1 2025.
- Average Receivables over 5 years is $4.6 million, with a median of $4.2 million recorded in 2022.
- The sharpest annual moves came in 2024 and 2025: Receivables jumped 1071.2% in 2024, then tumbled 97.45% in 2025.
- Over 5 years, Receivables stood at $6.4 million in 2021, then dropped by 29.36% to $4.5 million in 2022, then sank by 70.49% to $1.3 million in 2023, then slumped by 60.33% to $526000.0 in 2024, then fell by 23.95% to $400000.0 in 2025.
- The last three Receivables figures came in at $400000.0 (Q4 2025), $523000.0 (Q3 2025), and $372000.0 (Q2 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.13 Bn | 9.29 Bn | 112.79 Mn | 138.70 Mn |
| 2 | CRISPR Therapeutics AG | 5.23 Bn | 5.23 Bn | - | - |
| 3 | Iovance Biotherapeutics | 3.82 Bn | 3.52 Bn | 55.72 Mn | 102.12 Mn |
| 4 | Legend Biotech | 3.68 Bn | 2.72 Bn | 251.50 Mn | - |
| 5 | uniQure | 3.08 Bn | 3.08 Bn | 5.49 Mn | 5.78 Mn |
| 6 | Beam Therapeutics | 2.67 Bn | 2.67 Bn | - | - |
| 7 | Precigen | 2.43 Bn | 2.43 Bn | 52.17 Mn | 72.04 Mn |
| 8 | Sarepta Therapeutics | 2.33 Bn | 1.54 Bn | 251.87 Mn | 421.82 Mn |
| 9 | Vericel | 2.00 Bn | 1.84 Bn | 56.40 Mn | 75.71 Mn |
| 10 | Sangamo Therapeutics | 43.15 Mn | 22.20 Mn | - | 400,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 400,000.00 |
| Sep 30, 2025 | 523,000.00 |
| Jun 30, 2025 | 372,000.00 |
| Mar 31, 2025 | 366,000.00 |
| Dec 31, 2024 | 526,000.00 |
| Sep 30, 2024 | 20.50 Mn |
| Jun 30, 2024 | 581,000.00 |
| Mar 31, 2024 | 691,000.00 |
| Dec 31, 2023 | 1.33 Mn |
| Sep 30, 2023 | 1.75 Mn |
| Jun 30, 2023 | 3.94 Mn |
| Mar 31, 2023 | 8.05 Mn |
| Dec 31, 2022 | 4.49 Mn |
| Sep 30, 2022 | 5.05 Mn |
| Jun 30, 2022 | 6.29 Mn |
| Mar 31, 2022 | 7.29 Mn |
| Dec 31, 2021 | 6.36 Mn |
| Sep 30, 2021 | 8.59 Mn |
| Jun 30, 2021 | 7.69 Mn |
| Mar 31, 2021 | 7.72 Mn |